Mach7 Technologies Graham Number
The Graham Number of Mach7 Technologies (M7T.AX) as of Nov 11, 2026 is 0.06 AUD.
Get this data via API
Financial Data API
Graham Number
0.06AUD
Last updated:
Graham Number of Mach7 Technologies is 2020 0.06 AUD. Graham Number of Mach7 Technologies was 2019 - AUD. It decreases by % lower compared to the previous year.
The Mach7 Technologies Graham Number history
| YEAR | Graham Number | YoY |
|---|---|---|
| 0.06AUD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Mach7 Technologies Stock analysis
What does Mach7 Technologies do? Mach7 Technologies Ltd. generates revenue through its medical imaging software and services for healthcare institutions. The company offers the Mach7 Enterprise Imaging Solution, which includes Enterprise Data Management, Enterprise Diagnostic Viewing, and Departmental Workflow applications. Enterprise Data Management features a Vendor Neutral Archive (VNA) and data administration tools for fast storage, access, retrieval, and viewing of images across healthcare networks with cloud connectivity. Enterprise Diagnostic Viewing provides consolidated access to patient images and data for healthcare professionals, enabling timely diagnosis and treatment. The company serves global healthcare enterprises across North America, Asia Pacific, and the Middle East regions.
Mach7 Technologies Ltd. targets healthcare institutions as its primary customers, including hospitals and medical facilities that require advanced imaging and data management solutions. The core products, Mach7 Enterprise Imaging Solution and its components, are sold to these institutions to streamline workflows and improve patient care. The company's focus on global healthcare enterprises ensures a broad market reach in key regions, supporting its revenue streams through software licensing and service contracts.
The principal activity of Mach7 Technologies Ltd. is the development and commercialization of medical imaging and data management software solutions. The firm's offerings are designed to meet the needs of healthcare enterprises by providing integrated tools for image storage, access, and diagnostic viewing. By focusing on the North America, Asia Pacific, and Middle East regions, the company capitalizes on the growing demand for efficient healthcare data management systems, driving sales of its software solutions to healthcare institutions. Mach7 Technologies is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Mach7 Technologies stock
Graham Number of Mach7 Technologies is 0.06 AUD in 2020.
On Eulerpool you can find the complete historical development of Graham Number Mach7 Technologies since 2006 – with annual values, charts, and detailed analysis.
The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Mach7 Technologies
All Key Metrics — Mach7 Technologies
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth